In his first term, President Donald Trump launched a bold and successful initiative against HIV. This time around, the ...

The latest Westpac CEO100 Survey reveals a positive shift in business sentiment. However, the survey also highlights five key concerns impeding business growth in Papua New Guinea.

Efavirenz, an HIV drug, shows potential for treating chikungunya virus, inhibiting replication and reducing viral load ...

Gilead (GILD) stock in focus as its HIV anti-viral lenacapavir shows promise in HIV prevention with once-yearly PrEP ...

HIV self-testing has been available since 2012 ... providing an opportunity for post-test assistance and linkage to care or preventative measures like PrEP. We also know the importance of trusted ...

It’s a tapu subject,” said Milly Stewart, a specialist indigenous service provider pushing for more public education around ...

For the majority of people with the virus in the U.S., dying with HIV has turned into living a long life with HIV.

Researchers from the HIV Prevention Trials Network (HPTN) presented results from the HPTN 094 (“INTEGRA”) study at the 2025 ...

GSK’s ViiV Healthcare has shared clinical data on three potential long-acting HIV treatments, providing a look at how its plans to create a six-month regimen are shaping up. ViiV, which is ...

USAid’s funding withdrawal has put nearly 700 health workers out of jobs and threatens R360 million worth of HIV and TB support services. Nacosa’s vital community programs, including HIV prevention, ...

The trial enrolled 40 healthy adults aged 18-55 who had a low risk for HIV infection. “Once-yearly lenacapavir, if approved, could become an important new HIV prevention option that could help ...